Nathanel Zelnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nathanel Zelnik has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Aaron Lerner
From the Department of Pediatrics, Carmel Medical Center, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
2 shared publicationsMiriam David
2 shared publicationsOdeya Bennett-Back
The Department of Pediatrics, Carmel Medical Center and the B. Rappaport Faculty of Medicine, Technion, Haifa, Israel
2 shared publicationsAvi Pacht
From the Department of Pediatrics, Carmel Medical Center, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
1 shared publicationAviva Fattal-Valevski
Pediatric Neurology Unit, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
1 shared publicationBruria Ben-Zeev
Pediatric Neurology Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
1 shared publication
Latest Publications
- 28 February 2012
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 27 (6) , 703-707
Is the Test of Variables of Attention Reliable for the Diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD)?
The diagnosis of attention-deficit hyperactivity disorder (ADHD) is occasionally biased by the subjectivity of symptoms and reports of parents and teachers. The advent of continuous performance tests raised expectations that the diagnosis of ADHD will be more standardized and accurate. In this study, the authors looked for the validity of the ADHD scores obtained by the Test of Variables of Attention in 230 children who were referred to their ADHD clinic between 2005 and 2007. Based on clinical evaluations, 179 children were diagnosed with affirmed or suspected ADHD. Among the 179 children with ADHD, the Test of Variables of Attention was suggestive of ADHD in 163 participants (91.1% sensitivity), but it was also suggestive for ADHD in 78.4% of the children without ADHD. With a low specificity of 21.6%, the authors feel that the Test of Variables of Attention is not reliable enough to serve as a screening diagnostic tool for ADHD.
- 28 February 2012
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 27 (6) , 703-707
Is the Test of Variables of Attention Reliable for the Diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD)?
The diagnosis of attention-deficit hyperactivity disorder (ADHD) is occasionally biased by the subjectivity of symptoms and reports of parents and teachers. The advent of continuous performance tests raised expectations that the diagnosis of ADHD will be more standardized and accurate. In this study, the authors looked for the validity of the ADHD scores obtained by the Test of Variables of Attention in 230 children who were referred to their ADHD clinic between 2005 and 2007. Based on clinical evaluations, 179 children were diagnosed with affirmed or suspected ADHD. Among the 179 children with ADHD, the Test of Variables of Attention was suggestive of ADHD in 163 participants (91.1% sensitivity), but it was also suggestive for ADHD in 78.4% of the children without ADHD. With a low specificity of 21.6%, the authors feel that the Test of Variables of Attention is not reliable enough to serve as a screening diagnostic tool for ADHD.
- 1 January 2010
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 14 (1) , 67-72
Risk factors for epilepsy in children with cerebral palsy
- 1 January 2010
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 14 (1) , 67-72
Risk factors for epilepsy in children with cerebral palsy
- 1 July 2008
- Published by Elsevier in Pediatric Neurology
- Vol. 39 (1) , 18-21
Vigabatrin, Lamotrigine, Topiramate and Serum Carnitine Levels
- 1 July 2008
- Published by Elsevier in Pediatric Neurology
- Vol. 39 (1) , 18-21
Vigabatrin, Lamotrigine, Topiramate and Serum Carnitine Levels
- 1 June 2007
- Published by Elsevier in Pediatric Neurology
- Vol. 36 (6) , 411-413
A Novel Mutation of the CLN8 Gene: Is There a Mediterranean Phenotype?
- 1 June 2007
- Published by Elsevier in Pediatric Neurology
- Vol. 36 (6) , 411-413
A Novel Mutation of the CLN8 Gene: Is There a Mediterranean Phenotype?
- 1 September 2006
- Published by Georg Thieme Verlag KG in Journal of Pediatric Neurology
- Vol. 04 (03) , 147-153
Efficacy of corticosteroid therapy in treating epileptic encephalopathies and refractory epilepsies other than West syndrome
To evaluate the efficacy of steroid therapy in epileptic encephalopathies and refractory epilepsies other than West syndrome. Retrospective analysis of treatment and outcome data of patients treated with steroids for epileptic encephalopathies. Outcome was analyzed in terms of the patient’s epileptic syndrome, age at seizure onset, duration of seizure disorder, age at treatment, abnormalities noted on neurological examination, developmental status and type of steroid. Fifty-eight consecutive patients from six pediatric neurology outpatient clinics were included in the study. The epileptic syndrome and types were as follows: myoclonic epilepsy (n = 16), epilepsy with continuous spike waves during slow-wave sleep (n = 12), partial epilepsy (n = 10), Landau-Kleffner syndrome (n = 6), generalized epilepsy with multiple epileptic seizure types (n = 5), Rasmussen’s encephalitis (n = 3), Lennox-Gastaut syndrome (n = 2), atypical absence (n = 2) and spasms (n = 2). Sixteen patients (27%) had received adrenocorticotrophic hormone (ACTH) and 42 (73%) had received prednisone (22 of the latter patients were given initial pulse methylprednisolone). Complete cessation of seizures as well as disappearance of epileptic discharges in electroencephalogram were achieved in 16 patients (28%); 15 other patients (26%) had improvement of > 50%. Of the 31 patients with > 50% improvement and follow-up of at least 1 year, 16 (52%) subsequently relapsed. ACTH was found to be significantly more efficacious than prednisone in controlling seizures and improving function. Initiation of treatment with high-dose methylprednisolone did not increase efficacy. ACTH may be more efficacious than prednisone in treating epileptic encephalopathies and refractory epilepsies other than West syndrome.
- 1 September 2006
- Published by Georg Thieme Verlag KG in Journal of Pediatric Neurology
- Vol. 04 (03) , 147-153
Efficacy of corticosteroid therapy in treating epileptic encephalopathies and refractory epilepsies other than West syndrome
To evaluate the efficacy of steroid therapy in epileptic encephalopathies and refractory epilepsies other than West syndrome. Retrospective analysis of treatment and outcome data of patients treated with steroids for epileptic encephalopathies. Outcome was analyzed in terms of the patient’s epileptic syndrome, age at seizure onset, duration of seizure disorder, age at treatment, abnormalities noted on neurological examination, developmental status and type of steroid. Fifty-eight consecutive patients from six pediatric neurology outpatient clinics were included in the study. The epileptic syndrome and types were as follows: myoclonic epilepsy (n = 16), epilepsy with continuous spike waves during slow-wave sleep (n = 12), partial epilepsy (n = 10), Landau-Kleffner syndrome (n = 6), generalized epilepsy with multiple epileptic seizure types (n = 5), Rasmussen’s encephalitis (n = 3), Lennox-Gastaut syndrome (n = 2), atypical absence (n = 2) and spasms (n = 2). Sixteen patients (27%) had received adrenocorticotrophic hormone (ACTH) and 42 (73%) had received prednisone (22 of the latter patients were given initial pulse methylprednisolone). Complete cessation of seizures as well as disappearance of epileptic discharges in electroencephalogram were achieved in 16 patients (28%); 15 other patients (26%) had improvement of > 50%. Of the 31 patients with > 50% improvement and follow-up of at least 1 year, 16 (52%) subsequently relapsed. ACTH was found to be significantly more efficacious than prednisone in controlling seizures and improving function. Initiation of treatment with high-dose methylprednisolone did not increase efficacy. ACTH may be more efficacious than prednisone in treating epileptic encephalopathies and refractory epilepsies other than West syndrome.
- 1 June 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 113 (6) , 1672-1676
Range of Neurologic Disorders in Patients With Celiac Disease
Objective. During the past 2 decades, celiac disease (CD) has been recognized as a multisystem autoimmune disorder. A growing body of distinct neurologic conditions such as cerebellar ataxia, epilepsy, myoclonic ataxia, chronic neuropathies, and dementia have been reported, mainly in middle-aged adults. There still are insufficient data on the association of CD with various neurologic disorders in children, adolescents, and young adults, including more common and “soft” neurologic conditions, such as headache, learning disorders, attention-deficit/hyperactivity disorder (ADHD), and tic disorders. The aim of the present study is to look for a broader spectrum of neurologic disorders in CD patients, most of them children or young adults. Methods. Patients with CD were asked to fill in a questionnaire regarding the presence of neurologic disorders or symptoms. Their medical charts were reviewed, and those who were reported as having neurologic manifestations underwent neurologic examination and brain imaging or electroencephalogram if required. Their neurologic data were compared with that of a control group matched for age and gender. Results. Patients with CD were more prone to develop neurologic disorders (51.4%) in comparison with control subjects (19.9%). These disorders include hypotonia, developmental delay, learning disorders and ADHD, headache, and cerebellar ataxia. Epileptic disorders were only marginally more common in CD. In contrast, no difference was found in the prevalence of tic disorders in both groups. Therapeutic benefit, with gluten-free diet, was demonstrated only in patients with transient infantile hypotonia and migraine headache. Conclusion. This study suggests that the variability of neurologic disorders that occur in CD is broader than previously reported and includes “softer” and more common neurologic disorders, such as chronic headache, developmental delay, hypotonia, and learning disorders or ADHD. Future longitudinal prospective studies might better define the full range of these neurologic disorders and their clinical response to a gluten-free diet.
- 1 June 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 113 (6) , 1672-1676
Range of Neurologic Disorders in Patients With Celiac Disease
Objective. During the past 2 decades, celiac disease (CD) has been recognized as a multisystem autoimmune disorder. A growing body of distinct neurologic conditions such as cerebellar ataxia, epilepsy, myoclonic ataxia, chronic neuropathies, and dementia have been reported, mainly in middle-aged adults. There still are insufficient data on the association of CD with various neurologic disorders in children, adolescents, and young adults, including more common and “soft” neurologic conditions, such as headache, learning disorders, attention-deficit/hyperactivity disorder (ADHD), and tic disorders. The aim of the present study is to look for a broader spectrum of neurologic disorders in CD patients, most of them children or young adults. Methods. Patients with CD were asked to fill in a questionnaire regarding the presence of neurologic disorders or symptoms. Their medical charts were reviewed, and those who were reported as having neurologic manifestations underwent neurologic examination and brain imaging or electroencephalogram if required. Their neurologic data were compared with that of a control group matched for age and gender. Results. Patients with CD were more prone to develop neurologic disorders (51.4%) in comparison with control subjects (19.9%). These disorders include hypotonia, developmental delay, learning disorders and ADHD, headache, and cerebellar ataxia. Epileptic disorders were only marginally more common in CD. In contrast, no difference was found in the prevalence of tic disorders in both groups. Therapeutic benefit, with gluten-free diet, was demonstrated only in patients with transient infantile hypotonia and migraine headache. Conclusion. This study suggests that the variability of neurologic disorders that occur in CD is broader than previously reported and includes “softer” and more common neurologic disorders, such as chronic headache, developmental delay, hypotonia, and learning disorders or ADHD. Future longitudinal prospective studies might better define the full range of these neurologic disorders and their clinical response to a gluten-free diet.
- 21 May 2004
- Published by Wiley in Prenatal Diagnosis
- Vol. 24 (5) , 358-362
Identification of two mutations for ataxia telangiectasia among the Druze community
- 21 May 2004
- Published by Wiley in Prenatal Diagnosis
- Vol. 24 (5) , 358-362
Identification of two mutations for ataxia telangiectasia among the Druze community